| Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer M Frattini, C Ferrario, P Bressan, D Balestra, L De Cecco, P Mondellini, ... Oncogene 23 (44), 7436-7440, 2004 | 349 | 2004 |
| MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications S Busacca, S Germano, L De Cecco, M Rinaldi, F Comoglio, F Favero, ... American journal of respiratory cell and molecular biology 42 (3), 312-319, 2010 | 199 | 2010 |
| Limits of predictive models using microarray data for breast cancer clinical treatment outcome JF Reid, L Lusa, L De Cecco, D Coradini, S Veneroni, MG Daidone, ... Journal of the National Cancer Institute 97 (12), 927-930, 2005 | 144 | 2005 |
| Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood M Massimino, V Biassoni, R Miceli, E Schiavello, M Warmuth-Metz, ... Journal of neuro-oncology 118, 305-312, 2014 | 136 | 2014 |
| Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data L De Cecco, M Nicolau, M Giannoccaro, MG Daidone, P Bossi, L Locati, ... Oncotarget 6 (11), 9627, 2015 | 135 | 2015 |
| Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers G Liu, D Yang, R Rupaimoole, CV Pecot, Y Sun, LS Mangala, X Li, P Ji, ... JNCI: Journal of the National Cancer Institute 107 (7), djv108, 2015 | 128 | 2015 |
| miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma E Minna, P Romeo, L De Cecco, M Dugo, G Cassinelli, S Pilotti, ... Oncotarget 5 (9), 2513, 2014 | 117 | 2014 |
| Perfusion of isolated rat kidney with Mesenchymal Stromal Cells/Extracellular Vesicles prevents ischaemic injury M Gregorini, V Corradetti, EF Pattonieri, C Rocca, S Milanesi, A Peloso, ... Journal of Cellular and Molecular Medicine 21 (12), 3381-3393, 2017 | 116 | 2017 |
| Challenges in projecting clustering results across gene expression–profiling datasets L Lusa, LM McShane, JF Reid, L De Cecco, F Ambrogi, E Biganzoli, ... JNCI: Journal of the National Cancer Institute 99 (22), 1715-1723, 2007 | 116 | 2007 |
| Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study M Bagnoli, S Canevari, D Califano, S Losito, M Di Maio, F Raspagliesi, ... The lancet oncology 17 (8), 1137-1146, 2016 | 110 | 2016 |
| Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b E Vergani, L Di Guardo, M Dugo, S Rigoletto, G Tragni, R Ruggeri, ... Oncotarget 7 (4), 4428, 2016 | 104 | 2016 |
| Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer M Callari, V Cappelletti, L De Cecco, V Musella, P Miodini, S Veneroni, ... Breast cancer research and treatment 127, 601-610, 2011 | 104 | 2011 |
| Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2 LD Cecco, L Marchionni, M Gariboldi, JF Reid, MS Lagonigro, ... Oncogene 23 (49), 8171-8183, 2004 | 101 | 2004 |
| Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension I Bortolomai, S Canevari, I Facetti, L De Cecco, G Castellano, A Zacchetti, ... Cell cycle 9 (6), 1194-1206, 2010 | 100 | 2010 |
| miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma E Minna, P Romeo, M Dugo, L De Cecco, K Todoerti, S Pilotti, F Perrone, ... Oncotarget 7 (11), 12731, 2016 | 95 | 2016 |
| Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications D Mezzanzanica, M Bagnoli, L De Cecco, B Valeri, S Canevari The international journal of biochemistry & cell biology 42 (8), 1262-1272, 2010 | 93 | 2010 |
| Impact of biospecimens handling on biomarker research in breast cancer L De Cecco, V Musella, S Veneroni, V Cappelletti, I Bongarzone, ... BMC cancer 9, 1-14, 2009 | 91 | 2009 |
| Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltration T Triulzi, L De Cecco, M Sandri, A Prat, M Giussani, B Paolini, ... Oncotarget 6 (29), 28173, 2015 | 83 | 2015 |
| Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer M Di Modica, G Gargari, V Regondi, A Bonizzi, S Arioli, B Belmonte, ... Cancer Research 81 (8), 2195-2206, 2021 | 82 | 2021 |
| Induction of Paneth cell degranulation by orally administered Toll‐like receptor ligands C Rumio, M Sommariva, L Sfondrini, M Palazzo, D Morelli, L Viganò, ... Journal of cellular physiology 227 (3), 1107-1113, 2012 | 82 | 2012 |
